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Abstract
Background: Dendritic cells (DCs) play a key role in the induction of adaptive and memory immune responses. Upon
encounter with pathogens, they undergo a complex maturation process and migrate toward lymphoid organs where they
stimulate immune effector cells. This process is associated with dramatic transcriptome changes, pointing to a paramount
role for transcription factors in DC activation and function. The regulation and the role of these transcription factors are
however ill-defined and require characterization. Among those, AP-1 is a family of dimeric transcription complexes with an
acknowledged role in the control of immunity. However, it has not been studied in detail in DCs yet.
Methodology/Principal Findings: Here, we have investigated the regulation and function of one of its essential
components, JunB, in primary bone marrow–derived DCs induced to maturate upon stimulation by Escherichia coli
lipopolysaccharide (LPS). Our data show fast and transient NF-kB–dependent transcriptional induction of the junb gene
correlating with the induction of the TNFa, IL-6, and IL-12 proinflammatory cytokines. Inhibition of JunB protein induction
by RNA interference hampered the transcriptional activation of the TNF-a, IL-6, and IL-12p40 genes. Consistently, chromatin
immunoprecipitation experiments showed LPS-inducible binding of JunB at AP-1–responsive sites found in promoter
regions of these genes. Concomitant LPS-inducible NF-kB/p65 binding to these promoters was also observed.
Conclusions/Significance: We identified a novel role for JunB—that is, induction of proinflammatory cytokines in LPS-
activated primary DCs with NF-kB acting not only as an inducer of JunB, but also as its transcriptional partner.
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Introduction
Dendritic cells (DCs) are professional antigen-presenting cells
playing a key role in the induction of adaptive and memory
immune responses as well as in tolerance to self-antigens [1,2]. In
response to a variety of microbial and endogenous stimuli, they
capture antigens from their environment, which is followed by a
complex maturation process. For example, upon uptake of
pathogens, DC maturation typically includes major changes in
the repertoire of surface receptors, acquisition of a migratory
phenotype towards lymphoid organs, secretion of soluble media-
tors such as pro-inflammatory cytokines like TNF-a, IL-6 or IL-12
and induction of costimulatory- and MHC class I and II
molecules, which are essential for eventual stimulation of effector
lymphocytes [1,2].
To detect microbial products and certain non-microbial
endogenous factors, DCs are equipped with different cell surface
molecular platforms. These receptors are, not only instrumental
for antigen uptake, but also for induction of DC maturation via the
activation of various signaling pathways [1]. Among them, the
family of evolutionary conserved Toll-like receptors (TLRs) is
central to the regulation of protective immune responses in
pathogen-infected hosts [3]. For example, TLR4 binds the
lipopolysaccharide (LPS) from Gram-negative bacteria such as
E. coli [3] and activates various intracellular signaling cascades.
Yet, these pathways that, importantly here, include the NF-kB-
and AP-1 transcription complex pathways, have essentially been
studied in non-DC cells [4,5,6].
DC maturation is associated with marked transcriptome
reprogramming. Upon infection by pathogens, more than 1000
mRNA level changes can be monitored in DNA array studies with
both core responses common to all activators and pathogen-
specific programs of gene expression (for a review, see ref. [7]).
These studies point to a paramount role for transcription factors.
Indeed, it is notable that in macrophages, which are phagocytes
closely related to DCs, stimulation by E. coli LPS entails mRNA
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[8], indicating a high degree of complexity in the regulation of
TLR4-induced genes. It is however important to bear in mind
that, despite the lineage proximity, transcriptional programs show
significant differences between macrophages and DCs [7]. This is,
for example, illustrated by differential induction of co-stimulatory
molecules upon TLR4 stimulation [9].
The ubiquitous AP-1 transcriptional complex comprises a large
family of dimeric transcription factors binding to AP-1/TREs
(TPA-Responsive Elements) or CREs (cAMP-Responsive Ele-
ments) DNA motifs found in many gene promoters and enhancers.
This explains that AP-1 is involved in the control of many
physiological functions. Among the best-studied AP-1 components
are the Jun family proteins (c-Jun, JunB and JunD). They can
either homodimerize or heterodimerize between them or hetero-
dimerize with other transcription factors, the best known of which
are the Fos family members (c-Fos, Fra-1, Fra-2 and FosB) [10,11].
AP-1 activates or represses transcription, depending on the dimer
composition, the target gene, the cell context, the extracellular
environment and which intracellular signaling cascades are
activated [10,11]. Extensive investigations in many in vitro and in
vivo experimental systems have shown that the individual AP-1
subunits have many independent functions [12,13,14]. An
important consequence of this is that the role of each AP-1
protein must be studied individually in any given situation.
Moreover, such studies are complicated by the fact that certain
AP-1 proteins can oscillate between activator and repressor states
according to a variety of circumstantial factors that include their
post-transcriptional modifications. For example, c-Fos or c-Jun
transactivating activities are stimulated by a number of specific
phosphorylations (see ref. [15] and references therein), whereas the
same proteins are turned into transcriptional repressors upon
sumoylation [16,17].
AP-1 has been implicated in the control of immune functions,
which include cytokine gene induction, in non-DC contexts such
as macrophages, B-, T- and mast cells where it can collaborate
with NF-kB [14]. This collaboration relies on a variety of factors.
Among those, one can cite frequent concomitant activations of
AP-1 and NF-kB, the vicinity of many AP-1- and NF-kB-
responsive DNA motifs in gene promoters and the possibility of
physical interactions between the two transcriptional complexes
(see [18,19] for references). Additionally, NF-kB and AP-1 can
cross-regulate their expressions in a variety of situations [18,19].
Surprisingly, despite the well established role of AP-1 in the
regulation of immunity, little is known on its implication in DC
biology. Our present knowledge is essentially limited to studies in
cultured DC cell lines with no real investigations in primary cells.
Except for a few functional reports, these studies have character-
ized the expression of certain AP-1 components in DCs and
detected variations in overall AP-1 activity upon stimulation of
various sorts with no specific investigation on specific Jun or Fos
proteins [7,20,21,22,23,24] or on collaboration with other
signaling pathways.
To begin to unravel AP-1 function in DCs, we have focused
here on the role of its JunB component. As, to our knowledge, no
DC cell line fully recapitulates all of the biological properties of
primary DCs, we have conducted our study using primary mouse
bone marrow-derived DCs (BMDCs) that were activated by E. coli
LPS (referred to as ‘‘LPS’’ hereafter). Our choice of JunB is
justified by several reasons. First, the junb gene is rapidly induced
by a plethora of stimuli in many different cell types, including LPS-
stimulated macrophagic and -pre-B lymphocytic cell lines [19,25].
Transcriptome analyses have also allowed to identify junb mRNA
changes in DCs [7]. Yet, no kinetic studies were conducted and no
protein analysis was conducted. Second, JunB is known to regulate
cytokine and chemokine genes in cell types other than DCs,
although it is not always clear whether the mechanisms involved
are direct or indirect [18,19,26,27,28,29,30,31,32,33] (see discus-
sion). Third, JunB is a direct transcriptional target of NF-kBi n
various situations that include stimulation of 70Z/3 pre-B cells by
LPS [19]. Moreover, JunB functionally collaborates with NF-kB, a
transcription factor with essential role in DC activation [34], to
activate the CCR7 gene in this cell line. Using a combination of
qPCR, chromatin-immunoprecipitation (ChIP) and RNA inter-
ference approaches, we show that transcriptional induction of
endogenous JunB is under direct control of LPS-activated NF-kB
and essential for subsequent activation of genes coding for the
proinflammatory cytokines TNF-a, IL-6 and IL-12 in LPS-
stimulated BMDCs. Our data also suggest a collaboration
between NF-kB and JunB in the transcriptional induction of
these genes.
Materials and Methods
BMDC Preparation and Cell Cultures
Bone-marrow-derived DCs were obtained from bone marrow
precursors of 6 to 7-week-old 129/Sv/Ev mice as described in
Winzler et al. [35]. Briefly, bone marrow cells were withdrawn
from the femurs and tibias. Red cells were lysed using the ACK
lysis buffer from Amersham. B- and T lymphocytes were
eliminated by negative depletion using the anti-CD19 and anti-
CD90 magnetic beads from Miltenyi Biotech and monocytes by
adherence on plastic plates. Cells were cultured for 7 days in
RPMI 1640 medium supplemented with 5% fetal calf serum, 2
mM Glutamine, 50 mM b-mercaptoethanol, 1 mM sodium
pyruvate, 1 mM non essential amino acids, 200 U/ml GM-CSF
and 200 U/ml IL-4 (Peprotech). The culture medium was
replaced every 2 days. The purity of the BMDC population was
assessed by flow cytometry after double MHC class II and CD11c
labelling.
BMDC Stimulation and IKK Pharmacological Inhibition
Contaminants in E. coli LPS preparations from various suppliers
can activate TLR2. We therefore resorted to ultrapure E. coli LPS
from Invivogen as it is tested for exclusive stimulation of TLR4. It
was used at a concentration of 1 mg/mL. The BAY 11-7085
(Calbiochem) inhibitor was used at a final concentration of
10 mg/mL.
qRT-PCR Analyses
Total RNA from BMDCs was prepared using the GenElute
TM
Mammalian Total RNA Miniprep kit from Sigma. After treatment
with RNAse-free DNAse I (Promega), 1 mg of total RNA was used
for cDNA synthesis using Oligo(dT)15 (Promega) and the
Superscript III Reverse Transcriptase from Invitrogen according
to the supplier specifications. After 10-fold dilution, 2 ml of cDNA
were used for real-time PCR analysis using the Roche LightCycler
480 real-time PCR system. The sequences of the amplification
primers are presented in Table 1. Data analyses were performed
using the LightCycler software (Roche) and normalized with
respect to invariant S26 mRNA levels.
Immunoblotting Analyses
LPS-stimulated or untreated cells were scrapped from culture
dishes and directly lysed in SDS-containing electrophoresis
loading buffer. Total cell extracts were boiled for 5 minutes and
fractionated by PAGE before electrotransfer on PVDF mem-
branes (Millipore). Immunodetections were carried out as
JunB in Dendritic Cells
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JunB (kind gift from Dr M. Yaniv, Paris) or various antisera from
SantaCruz Biotechnology directed to JunD (Sc-74), c-Jun (Sc-45),
IkBa (Sc-371) and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH; Sc-25778). GAPDH was used as an internal invariant
control in our experiments. Final detection was carried out using
HRP-conjugated anti-antibody reagents from Santa-Cruz Bio-
technology, the enhanced chemolumiscence (ECL) kit from
Millipore and the Biomax XAR films from Kodak. When
necessary chemoluminescence signals were quantified using the
Genegnome device from Ozyme.
Indirect Immunofluorescence Assay
Intracellular localisation of p65/RelA was followed up by
indirect immunofluorescence on paraformaldehyde-fixed cells as
described in Malnou et al. [38,39] using the Sc-372 antibody from
Santa-Cruz Biotechnology.
TNFa, IL-6, IL-12p70 ELISA
TNFa, IL-6 and IL-12p70 were assayed from LPS-stimulated
BMDCs culture supernatants using the ELISA Ready-SET-Go!
kit from eBioscience.
Flow Cytometry Analysis
Fluorescent monoclonal antibodies directed to CD11c, CMHII,
CD40 and CD80 were obtained from BD Biosciences and
Miltenyi Biotec. After cell staining, fluorescence was assayed using
the FACSCalibur flow cytometer from BD Immunocytometry
Systems and the data were processed using the Cellquest Pro and
FlowJo softwares.
SiRNA Transfections
For RNAi experiments, either a scrambled control or a smart-
pool siRNAs (Dharmacon) against JunB (100 ng per 5610
5 cells)
Table 1. Oligonucleotide sequences for qRT-PCR (A) and ChIP (B) experiments.
A
JunB Forward 59-CAGCTACTTTTCGGGTCAGG-39
Reverse 59-ACGTGGTTCATCTTGTGCAG-39
c-Jun Forward 59-CATAGCCAGAACACGCTTCC-39
Reverse 59-AGTTGCTGAGGTTGGCGTAG-39
JunD Forward 59-ATCGACATGGACACGCAAGG-39
Reverse 59-ACGTGGCTGAGGACTTTCTG-39
IL-6 Forward 59-TTGCCTTCTTGGGACTGATGCT-39
Reverse 59-GTATCTCTCTGAAGGACTCTGG-39
TNF-a Forward 59-GTGACCTGGACTGTGGGCCTC-39
Reverse 59-GGCTCTGTGAGGAAGGCTGTG-39
IL-12p40 Forward 59-CAGAAGCTAACCATCTCCTGGTTTG-39
Reverse 59-TCCGGAGTAATTTGGTGCTTCACAC-39
IL-12p35 Forward 59-CACCCTTGCCCTCCTAAACC-39
Reverse 59-GGTTTGGTCCCGTGTGATGT-39
S26 Forward 59-GAACATTGTAGAAGCCGCTGCTGTC-39
Reverse 59-AACCTTGCTATGGATGGCACAGCTC-39
B
JunB Enhancer Forward 59-TATCCCCTGAGTCCTGGCACC-39
Reverse 59-CGCTGGCGTCACTGAGCTGAA-39
JunB Distal region Forward 59-CAGCCCCTTCAGAGAGTGGAG-39
Reverse 59-GGCAGTGACACCATCAAGCCC-39
TNFa Promoter Forward 59-TCCTTGATGCCTGGGTGTCCC-39
Reverse 59-GCAGACGGCCGCCTTTATAGC-39
TNFa Distal region Forward 59-CCACCCCACCCCTGCCATTTT-39
Reverse 59-CTGGGTCACCTGGAACTCTCC-39
IL-6 Promoter Forward 59-TCCAATCAGCCCCACCCACTC-39
Reverse 59-GGTGGGCTCCAGAGCAGAATG-39
IL-6 Distal region Forward 59-CCAAACATCCTCCCCCAAATC-39
Reverse 59-GGCATCTCTCACTCACCATCT-39
IL-12p40 Promoter Forward 59-AAGCACCAGGAGCAGCCAAGG-39
Reverse 59-GCAGGGAGTTAGCGACAGGGA-39
IL-12p40 Distal region Forward 59-CCCGATGCCCCTGGAGAAACA-39
Reverse 59-GGAGCAGCAGATGTGAGTGGC-39
doi:10.1371/journal.pone.0009585.t001
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according to the manufacturer’s recommendations.
Chromatin Immunoprecipitation Analyses
10
6 cells were fixed in 1% formaldehyde at room temperature
for 7.5 min. Fixation was blocked with 125 mM glycine final. Cells
were scraped and rinsed twice with phosphate-buffered saline
(PBS), allowed to lyse in 1 ml of cell lysis buffer (5 mM PIPES
pH 7.4, 85 mM KCl, 0.5% NP40+protease inhibitor cocktail
from Boehringher Manheim) at 0uC for 10 min. Nuclei were
recovered by centrifugation at 4uC and lysed in 500 ml nucleus
lysis buffer (50 mM Tris-HCl pH 7.5, 1% SDS, 10 mM EDTA +
protease inhibitor cocktail) at 0uC for 2 hours. 250 ml of each
sample were sonicated (at maximal power) using the Bioruptor
UCD-200 sonifier (Diagenode) through 30 cycles of 30 seconds
ON and 30 seconds OFF. Samples were incubated under
rotational agitation at 4uC overnight in the presence of 2 mgo f
either a specific antibody or a pre-immune serum taken as
negative control. Antibodies (Sc73 and Sc-372 from Santa-Cruz
Biotechnology for JunB and p65/RelA, respectively) were
previously bound to Dynabeads (Invitrogen) according to the
supplier’s recommendations. Dynabeads-bound immunoprecipi-
tates were sequentially washed once with a low salt buffer (50 mM
Tris-HCl pH 7.5, 150 mM NaCl, 1% triton, 0.1% SDS, 1 mM
EDTA), a high-salt buffer (50 mM Tris-HCl pH 7.5, 500 mM
NaCl, 1% triton, 0.1% SDS, 1 mM EDTA) and a LiCl-containing
buffer (20 mM Tris-HCl pH 7.5, 250 mM LiCl, 1% NP40, 1%
Na deoxycholate, 1 mM EDTA) and, then, twice with a TE buffer
(10 mM Tris-HCl pH 7.5, 1 mM EDTA). After elution in 250 ml
of elution buffer (100 mM NaHCO3, 1% SDS), DNA-protein
complexes were incubated at 65uC for 5 hours to reverse
crosslinks. Proteins and contaminating RNA were digested by
incubation in the presence of 100 mg/ml proteinase K and
100 mg/ml RNAse A at 45uC for 2 hours. DNA was purified on
Nuclear Extract II columns (Macherey-Nagel) according to the
manufacturer’s recommendations and then subjected to qPCR
analysis using the Roche LightCycler 480 real-time PCR system.
The data were normalized with inputs taken from samples before
the immunoprecipitation and treated under the same conditions.
The primers used to amplify the relevant regions of the junb and
cytokine gene promoters are listed in Table 1. In all cases, AP-1-
and NF-kB site-devoid fragments located downstream of the genes
of interest were used as negative controls to exclude non-specific
binding of JunB or NF-kB (not shown).
Results
Induction of JunB in Dendritic Cells
We exclusively used primary mouse bone marrow-derived DCs
(BMDCs) in the herein study. They were classically amplified from
bone marrow cells cultured for 7 days in the presence of GM-
CSF+IL-4. Flow cytometry analysis of MHC class II and CD11c
surface markers showed that they were reproducibly .80% pure
(Figure 1A). Their proper activation by ultrapure E. coli LPS (see
Materials and Methods) under our experimental conditions was
verified by monitoring their morphological change by microscopic
observation (not shown), the induction of the CD40 and CD80 cell
surface markers by flow cytometry [1] (Figure 1B) and the
induction of the proinflammatory cytokines TNF-a, IL-6 and IL-
12 by ELISA (Figure 1C).
As a first step to our investigations, we asked whether JunB was
induced by LPS treatment of BMDCs. To this aim, protein and
mRNA levels were assayed by immunoblotting at various time
points (Figure 2A) and qRT-PCR (Figure 2B), respectively. c-
Jun and JunD being potential transcriptional partners (see
discussion), we also followed them up in parallel. At the protein
level, the 3 Jun proteins were induced, albeit to different degrees
and with different kinetics. Our data can be summarized as
follows: (i) the induction of JunB was fast (detectable as early as
1 hour post-stimulation) and continued steadily for the whole
duration of the experiment, (ii) c-Jun was also induced rapidly, but
more modestly than JunB, and this induction rapidly reached a
plateau (by 1 hour post-stimulation) that was stable for the whole
duration of the experiments and (iii) JunD was modestly induced
during the initial phase of LPS stimulation but dramatically at the
latest time point tested (24 hours). Strikingly, the patterns of
mRNA accumulations were different from those of proteins with a
transient induction by 1 hour post-stimulation followed by a rapid
return to basal level. The extents of transient induction were
however different among the 3 jun mRNAs: that of jund mRNA
was the most modest (,2-fold), followed by that of c-jun (3-4-fold)
and, then, that of junb (4-5-fold). Most probably due to, on the one
hand, some variability between the various BMDC preparations
we made and, on the other hand, the fact that primary DCs
constitute a relatively heterogeneous population of cells at different
stages of maturation, it must be noted that inductions peaked
between 0.5 and 1.5 hours depending on the experiment with,
however, reproducible return to basal level by 4 hours. c-Jun and
JunB proteins being instable in other situations [37,40], it is likely
that their persistent accumulation in BMDCs was, at least
partially, due to strong stabilization in these cell lineage.
Supporting this possibility, cycloheximide chases indicated half-
lives much longer than 4 hours for JunB in both LPS-stimulated
and non-stimulated BMDCs (not shown). Moreover, increased
mRNA translation contributing to higher accumulation in LPS-
stimulated BMDCs cannot be excluded at this stage of
investigation. Protein stabilization and/or increased mRNA
translation should also account for the strong induction of JunD
protein seen at 24 hours post-stimulation.
NF-kB-Dependent Induction of the junb Gene in LPS-
Stimulated BMDCs
Then, we investigated whether the induction of the junb gene was
dependent on NF-kB in LPS-activated BMDCs. The p65/p50 NF-
kB transcription complex is maintained inactive in the cytoplasm by
the IkBa inhibitor but phosphorylation of IkBa by the IKK kinase
upon activation of cells by various stimuli entails IkBa degradation
within minutes and subsequent release of active NF-kB [1,34].
Importantly, NF-kB induction is generally transient due to rapid
resynthesis of IkBa in an NF-kB-dependent manner [1,34]. To
prevent NF-kB induction, siRNA against p65/RelA or transfection
of a transdominant mutant of IkBa are classically used when
carrying out experiments with established cell lines. We, however,
could not resort to these approaches as anti-p65/RelA siRNAs
revealed highly toxic to BMDCs (not shown) and unability to
transfect BMDCs with plasmids is a major limitation of this system.
Therefore, BMDCs were stimulated with LPS in the absence or in
the presence of the BAY11-7085 inhibitor with well-established
specificity for IKK [41,42,43] and JunB expression was analysed by
immunoblotting. Two lines of evidence indicated efficient IKK
inhibition in BMDCs by BAY-11-7085. First, p65/RelA, as assayed
by indirect immunofluorescence, accumulated in the nucleus of
95% of LPS-stimulated cells in the absence of the drug but localized
in the cytoplasm of 95% of LPS-stimulated cells in its presence
(Figure 3A). Second, the degradation of IkBa was inhibited by
BAY11-7085 (Figure 3B). Interestingly, the data of Figure 3B
showed a strong inhibition of JunB induction in BAY11-7085-
treated BMDCs, which implicated, directly or indirectly, the NF-kB
JunB in Dendritic Cells
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9585pathway. Worth of note, IkBa disappearance, which roughly
corresponds to maximal NF-kB activity, was contemporary to junb
mRNA induction. Additionally, we investigated the timing of NF-
kB binding to the junb gene. In other cell types, transcriptional
activation of junb by NF-kB has been reported to be principally
mediated by an enhancer harboring 4 NF-kB-binding sites and
located approximately 200 bp downstream the junb polyadenylation
Figure 1. Characterization of E. coli LPS-induced BMDC
maturation. (A) Purity of BMDCs. Bone marrow cells were cultured in
the presence of GM-CSF and IL-4 for 7 days and analyzed by flow
cytometry for the presence of CD11c and MHC II. (B) Induction of CD40
and CD80 by LPS. BMDCs were LPS-stimulated for 24 hours and
analyzed for the induction of CD40 and CD80 by flow cytometry. Error
bars correspond to standard deviation from 5 independent experi-
ments. (C) Cytokine induction. BMDCs were LPS-stimulated for the
indicated periods of time and cytokines were assayed from culture
supernatant by ELISA. The presented data correspond to a represen-
tative experiment.
doi:10.1371/journal.pone.0009585.g001
Figure 2. Expression of Jun proteins and jun mRNAs in LPS-
stimulated BMDCs. (A) Expression of the Jun proteins. BMDCs were
stimulated by LPS and c-Jun, JunB and JunD levels were assayed by
immunoblotting. A representative experiment out of 5 is shown.
GAPDH was used as an invariant electrophoresis loading control. JunD
classically appeared as 3 bands whose exact molecular natures are still
not elucidated. (B) Expression of jun RNAs. BMDCs were stimulated by
LPS and c-jun, junb and jund mRNA levels were assayed by qRT-PCR. As
inductions of junb and c-jun mRNAs peaked at different times ranging
from. 5 to 1.5 hour post-stimulation, depending on the BMDC
preparation, no error bar is presented. Instead, 1 representative
experiment out of 5 is presented.
doi:10.1371/journal.pone.0009585.g002
JunB in Dendritic Cells
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tion experiments (ChIP) showed a fast and transient inducible
binding of NF-kB/p65 in this region that coincided with junb
mRNA induction by LPS (Figure 2B). A typical ChIP experiment
is presented in Figure 4B. However, the peak of NF-kB fixation on
the junb enhancer could vary between 1 and 2 hours from one
experiment to the other due to the already mentionned heteroge-
neity of BMDCs.Moreover, in keepingwith inhibitionof bothIkBa
degradation and nuclear translocation of p65/RelA by BAY11-
7085, binding of p65/RelA to the junb enhancer was dramatically
reduced in the presence of the drug (Figure 4C). Thus, altogether
our data indicate that the induction of JunB in LPS-stimulated
BMDCs results from a direct transcriptional induction of the junb
gene by NF-kB.
Inductions of TNF-a-, IL-6- and IL-12p40 mRNAs Depend
on That of JunB in LPS-Activated BMDCs
Next, we asked whether JunB is involved in the transcriptional
regulation of inflammatory cytokines such as TNF-a, IL-6 and IL-
12 in LPS-stimulated BMDCs as their genes are well known
targets of AP-1 in other cell types [23,44,45,46,47]. To this aim,
we inhibited JunB induction upon siRNA transfection in BMDCs
that were subsequently stimulated by LPS before kinetic analysis of
mRNAs for TNF-a, IL-6 and IL-12 by qRT-PCR. Under our
experimental conditions, the induction of JunB protein
(Figure 5A) and junb mRNA (Figure 5B) was reduced by 70%
by the anti-junb siRNA whereas a control siRNA had no effect
(Figure 5B). This extent of repression was consistent with the
fraction (70%) of transfected cells, as estimated from parallel
transfection with a fluorescent control dsRNA (not shown). The
data presented in Figures 5C and 5D show that, in the presence
of the control siRNA, the mRNAs for TNF-a and IL-6 were
induced rapidly and transiently with peaks of expression between 1
and 4 hours for TNF-a mRNA and by 4 hours for IL-6, i.e. after
the onset of JunB protein induction (also see discussion). In
contrast, in the presence of the anti-junb siRNA, inductions of these
mRNAs were reduced by 50 to 80%, depending on the time point
considered. IL-12 is made up of two chains: IL-12p40 and IL-
12p35. Although the genes for the two chains are inducible by a
variety of stimuli, only that for IL-12p40 is known to be AP-1-
responsive. Interestingly, the induction of IL-12p40 mRNA
(Figure 5E), but not that of IL-12p35 (Figure 5F), was inhibited
by the junb siRNA. This was consistent with an involvement of
JunB in the induction of one chain but not of the other, the latter
serving as a negative control in the above experiments.
AP-1/CRE responsive elements have already been identified in
the promoter regions of the TNF-a, IL-6 and IL-12p40 genes
([23,44,45,46,47]; Figures 6A). We therefore asked by ChIP
whether JunB bound specifically to these enhancer regions during
the course of cytokine mRNA induction. The data presented in
Figures 6B–D show that this was indeed the case. Taken with the
above-described experiments, this strongly suggested that transient
induction of TNF-a, IL-6 and IL-12p40 genes was contributed by
JunB. As NF-kB binding sites crucial for the induction of these
genes [23,44,45,46,47] are located in the vicinity of the AP-1 sites,
we also verified inducible binding of NF-kB/p65 in ChIP
experiments. Consistent with transient induction of NF-kBi n
DCs [1,34], binding peaked by 2 hours post-stimulation for the
TNFa and IL-6 genes and by 4 hours for the IL-12p40 gene
(Figures 6E–G).
Discussion
AP-1 has a recognized role in the control of immunity.
However, it has not yet been subjected to in-depth investigation
in DCs. As a first step to this study, we have asked here whether its
JunB component might have a role in the induction of pro-
inflammatory cytokine genes in response to E. coli LPS stimulation.
Due to the scarcity of established DC cell lines and the bias
associated with their use, we have conducted our experiments in
primary mouse bone marrow-derived dendritic cells.
Our data show that the junb gene is rapidly and transiently
induced in response to TLR4 signaling upon LPS activation of
BMDCs. This is consistent with observations by others in
macrophage- [25] and pre-B cell [19] lines as well as with
previous transcriptomic analyses in DCs (see [7]). We also showed
that junb induction in BMDCs is dependent on NF-kBa s
demonstrated by its inhibition by a pharmacological inhibitor of
IKK and the inducible binding of NF-kB/p65 to the main junb
Figure 3. Involvement of the NF-kB pathway in JunB induction
in BMDCs. (A) Inhibition of p65/RelA nuclear translocation by BAY11-
7085. BMDCs were left unstimulated or were stimulated by LPS in the
presence of either BAY 11-7085 or solvent (DMSO) for 1 hour. After cell
fixation, nuclei were stained with Hoescht 33342 and p65/RelA was
detected by indirect immunofluorescence. (B) Inhibition of JunB
induction by BAY11-7085. BMDCs were stimulated by LPS in the
presence of either BAY 11-7085 or solvent (DMSO) for various periods
of time. The levels of IkBa and JunB were assayed by immunoblotting,
taking GAPDH as an invariant electrophoresis loading control. The
experiments were reproduced 3 times.
doi:10.1371/journal.pone.0009585.g003
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conclusion, we observed in an LPS-stimulated mouse DC cell line
(DC2.4; [50]) that a junb reporter gene was no longer
transcriptionally induced in transient luciferase transactivation
assays when its NF-kB sites were mutated (data not shown) in
addition to BAY11-7085-inhibitable inductions of both JunB
protein and junb mRNA similar to those in BMDCs and transient
LPS-inducible binding of NF-kB/p65 to the junb enhancer. In
other cellular backgrounds, the activation of junb transcription has
been reported not to be due to enhanced initiation of transcription
but rather to the release of already transcriptionally engaged RNA
polymerases that are blocked just downstream (less than 100
nucleotides) of the transcription initiation site [51]. It will be
interesting to address this point in future experiments. Notewor-
thy, JunB protein induction is much longer lasting than that of junb
mRNA in LPS-stimulated BMDCs, which is largely contributed
by high protein stability in this cell lineage. This constrasts with
other situations where JunB has been shown instable but fits with
the notion of its regulatable turnover [37].
Our RNA interference experiments have demonstrated an
important role for JunB in the induction of the TNF-a, IL-6 and
IL-12 pro-inflammatory cytokine mRNAs in LPS-stimulated
BMDCs. This observation is interesting for two reasons: (i) among
the Jun proteins, investigations have essentially been restricted to
c-Jun when studying the transcriptional activation of such genes
[37] and (ii) JunB is often considered as a transcriptional repressor,
or a poor activator, despite its demonstrated direct role in the
induction of cytokines like IL-2, IL-4 [27,28,29] and VEGF [31],
or of the cyclin A gene [37,52] in various cell contexts. Our ChIP
analyses showed LPS-inducible association of JunB with the AP-1
responsive site of the TNF-a [45,46], IL-6 [23,44] and IL-12p40
[47] promoters that parallels the activation of these genes, as
assayed by qRT-PCR. Taken with the above-mentioned siRNA
experiments, this strongly argues for direct transcriptional
activation of TNF-a, IL-6 and IL-12p40 genes by JunB. Not
constituting a proof but consistent with this idea, preliminary data
indicate that BMDC stimulation via TLR7 entails delayed
induction of JunB, which is associated with delayed proinflamma-
tory cytokines production (data not shown).
At least three important issues relate to the transcriptional
partners of JunB in the transcriptional induction of TNF-a, IL-6
and IL-12p40 genes in LPS-stimulated BMDCs. The first issue is
whether JunB acts as a homodimer under this condition or
whether it has to heterodimerize with another AP-1-constituting
proteins. The latter possibility is all the more to be taken into
consideration that JunB affinity for itself is relatively low and that it
can heterodimerize with a variety of other b-Zip proteins [10].
Illustrating this possibility in another cell system, MafA cooperates
with JunB in Th2 T cells for inducing the IL-4 gene [29]. In
BMDCs, Fra-2 might represent a good candidate for several
reasons: (i) among the 4 Fos proteins, which are the highest affinity
partners of the Juns [10], it is the only one to be expressed in LPS-
treated BMDCs (unpublished data), which is a finding in
agreement with absence of c-Fos expression recently observed in
a similar setting [22], (ii) Fra-2 is induced with a kinetics
paralleling that of JunB and (iii) it is found associated with JunB
in co-immunoprecipitation experiments (unpublished data). Fur-
ther experiments will explore this point. The second issue concerns
the collaboration of JunB with NF-kB/p65. It is interesting to note
that both JunB and NF-kB/p65 are found contemporarily bound
Figure 4. Direct transcriptional regulation of junb by NF-kB in LPS-stimulated BMDCs. (A) Structure of the junb gene. junb has no intron
and is approximately 1900 bp long. The 4 kB sites are located within a 200 bp domain located approximately 200 bp downstream of the junb
polyadenylation signal. The grey bar with the inverted arrows (enh) indicates the enhancer-containing fragment which is amplified in ChIP
experiments to visualize NF-kB binding. The black bar with the inverted arrows (cont) located downstream the NF-kB enhancer region indicates the
amplified negative control fragment used in the ChIP experiments to exclude non-specific NF-kB binding. The numbers indicate nucleotide position
with respect to the transcription initiation site (+1). (B) NF-kB binding in LPS-stimulated BMDCs. BMDCs were stimulated for various periods of time
with LPS before ChIP analysis. NF-kB binding in the enhancer region is presented in arbitrary units as well as the parallel negative control ChIPs
carried out with a preimmune serum (PI). Calculations were made with respect to the amplification of the ‘‘cont’’ negative control fragment. The
presented data are representative of 3 independent experiments (see text). (C) Inhibition of NF-kB binding at the junb enhancer in the presence of
BAY11-7085. The same experiment as in B was conducted except that BAY11-7085 or DMSO was added together with LPS to BMDCs and incubation
allowed to proceed for 1 hour.
doi:10.1371/journal.pone.0009585.g004
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turned on. As NF-kB is an inducer of, not only TNF-a, IL-6 and
IL-12p40 genes [23,44,45,46,47], but also of junb in BMDCs (this
work), this points to the existence of a regulatory loop where NF-
kB induces one of its transcriptional partner for subsequent
induction of pro-inflammatory cytokine genes that constitutes an
essential step in the DC activation process. Such a regulatory loop
has already been observed upon LPS activation of the 70Z/3 pre-
B cell line for induction of the CCR7 chemokine receptor [19],
suggesting that this mechanism may apply in various cell types for
induction of different types of genes. Moreover, inhibition of IKK
by BAY11-7085 3 hours post-LPS stimulation (which permits
inhibition of NF-kB after JunB induction) led to reduction of TNF-
a, IL-6 and IL-12p40 gene transcription as assayed by qRT-PCR
(data not shown). The third issue relates to the fact that induction
of TNF-a, IL-6 and IL-12p40 mRNAs are not synchronous, IL-6
mRNA level increasing later than those of the other two mRNAs
(Figure 5). This points to the existence of factor(s) differentially
affecting the timing of transcriptional activation of these three
genes. It is possible that one such factor(s) may operate by delaying
binding of JunB to the IL-6 promoter as suggested by our ChIP
experiments (Figure 6B–D).
Finally, it is important to wonder about whether JunB is always
an activator of the TNF-a, IL-6 and IL-12p40 genes in BMDCs.
In fact, (i) ChIP experiments (Figure 6) indicate that JunB is still
present on the promoters of these genes after they have been
transcriptionally switched off, as deduced from the reduction in
their mRNA levels (Figure 5) and (ii) higher cytokine gene
expression is observed 24 hours post-LPS stimulation in the
presence of the anti-junb siRNA (Figure 5). As already mentioned
in the introduction, certain AP-1 proteins, including JunB, can
oscillate between activator and repressor states, depending on their
post-translational modifications [16,17,27]. It will therefore be
interesting to investigate this possibility for JunB in BMDCs.
Alternatively, it is also possible that progressive inhibition of NF-
kB after its peak of activation also contributes to turn JunB from
Figure 5. Involvement of JunB in the induction of TNFa, IL-6 and IL-12p40 mRNA induction in LPS-stimulated BMDCs. Effect of the
junb siRNA on JunB protein (A) and junb mRNA (B) inductions in LPS-stimulated BMDCs. BMDCs were transfected with either a siRNA directed to junb
mRNA (Sijunb) or a control siRNA (SICT). 24 hours later they were stimulated, or not, by LPS and JunB protein and junb mRNA were assayed by
immunoblotting and qRT-PCR, respectively. (C, D, E and F) expression of TNF-a-, IL-6-, IL12p40- and IL-12p35 mRNAs in SiRNA-treated, LPS-stimulated
BMDCs. mRNAs were assayed by qRT-PCR in SiRNA-transfected BMDCs that were stimulated by LPS for various periods of time. The data presented
correspond to 1 representative experiment out of 3 independent experiment.
doi:10.1371/journal.pone.0009585.g005
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PLoS ONE | www.plosone.org 9 March 2010 | Volume 5 | Issue 3 | e9585an transcriptional activator state into a repressor one at the level of
proinflammatory cytokine genes.
In conclusion, DCs are essential components of adaptive
immune responses and represent innovative therapeutical tools
against infectious diseases, cancer and allergies. It is therefore
essential to elucidate the molecular basis of their genetic
reprogramming upon stimulation of various sorts towards a better
understanding of immunity and improvement of DC-based
immunotherapies. As AP-1 is known to play a pivotal role in
regulation of the immune system and has hardly been studied in
DCs, we have addressed here the role of its JunB constituent in
LPS-stimulated BMDCs. Our data indicate that JunB is crucial for
the transcriptional induction of genes encoding TNF-a, IL-6 and
IL-12p40 in LPS-stimulated BMDCs and acts in concert with NF-
kB, which is not only its transcriptional partner, but also its
necessary inducer in response to LPS-activated TLR4 signaling.
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